176506-75-5

Upstream product

• 120444-24-8 D-3-deoxy-3-fluoro-myo-inositol 
• 129365-59-9 (3aS,4S,4aR,7aS,8S,8aS)-4-Benzyloxy-8-fluoro-2,2,6,6-tetramethyl-hexahydro-benzo[1,2-d;4,5-d']bis[1,3]dioxole 
• 129444-05-9 (3aS,4S,4aR,7aS,8S,8aS)-8-Fluoro-2,2,6,6-tetramethyl-hexahydro-benzo[1,2-d;4,5-d']bis[1,3]dioxol-4-ol 

Downstream Products

• 176506-68-6 Phosphoric acid dibenzyl ester (1S,2R,3R,4S,5R,6S)-2-benzyloxy-6-benzyloxymethoxy-3-(bis-benzyloxy-phosphoryloxy)-5-fluoro-4-(4-methoxy-benzyloxy)-cyclohexyl ester 
• 176506-67-5 C₄₃H₄₁FO₉ 
• 176506-66-4 Benzoic acid (1R,2S,3R,4S,5S,6S)-2-benzyloxy-5-fluoro-3,4-dihydroxy-6-(4-methoxy-benzyloxy)-cyclohexyl ester 

Relevant academic research and scientific papers

Synthesis of novel metabolically stable analogues of D-myo-inositol 1,4,5-trisphosphate

Starting from L-quebrachitol, syntheses and biological activities of three novel analogues of the cellular second messenger D-myo-inositol 1,4,5-trisphosphate (IP3), 3-deoxy-3-fluoro-D-myo-inositol 1,4-bisphosphate 5-phosphorothioate (1a), 3-deoxy-3-fluoro-D-myo-inositol 1,5-bisphosphate 4-phosphorothioate (1b), and 3-deoxy-3-fluoro-D-myo-inositol 1-phosphate 4,5-bisphosphorothioate (1c) are described.